Who We Are
Pioneering Fibrosis Innovation and Beyond
Pulmongene is a clinical-stage innovator in developing first-in-class treatments for pulmonary and fibrotic diseases.
Our focus is on identifying novel molecular drivers of lung and fibrotic diseases, and developing first-in-class therapies for patients worldwide.
Our Approach
Pulmongene is dedicated to uncovering novel molecular drivers for pulmonary fibrosis and pioneering first-in-class therapies for patients with fibrotic lung diseases and beyond…
Our Team
Leader
Scientific